Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Surgical Adhesion Barriers are medical implants that are used to reduce abnormal internal scarring, or adhesions, following surgery by separating the internal tissues and organs while they heal. GlobalData uses proprietary data and analytics to provide a comprehensive report on the surgical adhesion barriers market in Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the surgical adhesion barriers market in Australia was Baxter International followed by W. L. Gore & Associates, MAST Biosurgery, Integra LifeSciences and Ethicon.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Adhesions are bands of scar-such as tissue that form abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures. However, post-surgical adhesion has a considerable epidemiological and clinical impact mostly due to tissue damage caused by surgical traumas. Gel Surgical Adhesion Barriers are gel-based products directly applied or sprayed at the site (open or laparoscopic) of surgery to prevent adhesions between the tissue planes. Membrane Surgical Adhesion Barriers are available in the form of fabrics, films and membranes.
The surgical adhesion barriers market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size surgical adhesion barriers in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
